ApoB blood test: the number that beats LDL cholesterol
Every atherogenic particle carries exactly one ApoB. Why counting particles predicts risk better than measuring the cholesterol inside them.
Key takeaways
- Every atherogenic lipoprotein particle carries exactly one apolipoprotein B, so one ApoB measurement is a count of all of them.
- LDL-C measures the cholesterol inside particles. ApoB counts the particles. When they disagree, the particle count is the more informative number.
- Discordance is common in insulin resistance, high triglycerides and low HDL, where particles are smaller and cholesterol-poor.
- US guidelines list ApoB at or above 130 mg/dL as a risk-enhancing factor. Lower is generally considered better in the prevention literature.
- It does not require fasting in most protocols and is inexpensive, which makes it an easy addition to a panel.
LDL cholesterol tells you how much cholesterol is being carried. ApoB tells you how many particles are carrying it, and particles are what lodge in an artery wall.
Because each LDL, IDL, VLDL and Lp(a) particle carries exactly one apolipoprotein B molecule, one ApoB measurement counts all of them at once.
The two can disagree. Small, cholesterol-poor particles produce a reassuring LDL-C with a high particle count, which is the pattern most often missed on a standard panel.
The particle versus cholesterol distinction
Cholesterol does not travel loose in blood. It is carried inside lipoprotein particles, and it is the particle, not the cholesterol, that crosses into an artery wall and starts the process that becomes plaque.
That distinction is the whole argument for ApoB. Apolipoprotein B is the structural protein on the surface of every atherogenic particle: LDL, IDL, VLDL, chylomicron remnants and Lp(a). Each of those particles carries exactly one. Measure ApoB and you have counted them.
LDL cholesterol, by contrast, tells you how much cholesterol those particles happen to be carrying. That is a related quantity, and often a reasonable proxy, but it is not the same measurement.
When LDL-C and ApoB disagree
Two people can have the same LDL-C with meaningfully different particle counts. Cholesterol-rich particles carry more cargo per particle, so a given LDL-C is spread across fewer of them. Cholesterol-poor particles carry less each, so the same LDL-C requires more particles to transport it.
The second pattern travels with insulin resistance, elevated triglycerides and low HDL. It is the pattern where a standard panel is most likely to look acceptable while ApoB is not, and it is common in exactly the population that thinks it has been cleared.
- High triglycerides with low HDL: check ApoB, because LDL-C may understate the particle burden.
- Metabolic syndrome or type 2 diabetes: discordance is more likely, not less.
- An LDL-C that seems inconsistent with your family history or imaging: ApoB is the tiebreaker worth having.
How the number is interpreted
The 2018 AHA and ACC cholesterol guideline names ApoB at or above 130 mg/dL as a risk-enhancing factor, a threshold that corresponds roughly to an LDL-C of 160 mg/dL. European guidance from the ESC and EAS treats ApoB as an alternative primary measurement rather than an optional add-on, with progressively lower targets as baseline risk rises.
What the literature does not support is a single universal cutoff for everyone. The target depends on your overall risk, which is why the number is interpreted alongside blood pressure, family history, Lp(a), metabolic markers and, where appropriate, imaging. That interpretation belongs to a clinician looking at your whole picture.
Practical notes on testing
ApoB is a standard immunoassay, widely available, inexpensive, and generally does not require fasting. If you are already having lipids drawn, adding it is usually trivial.
One caution on tracking: compare ApoB to previous ApoB values, ideally from the same laboratory. Comparing an ApoB against last year's LDL-C is not a trend, it is two different measurements.
How Baseline uses it
We recommend ApoB on the optional intake panel and, if you choose lab work, a repeat around the quarterly point, because the useful question is direction rather than a single snapshot.
Where it sits alongside metabolic markers matters. An elevated ApoB with high fasting insulin and high triglycerides describes a different problem, and a different plan, than an elevated ApoB in someone metabolically healthy with a strong family history.
What this means for you
Ask for ApoB the next time lipids are drawn, especially if your triglycerides are high or your HDL is low. If your LDL-C looks fine, ApoB is how you find out whether that is the whole story.
References
- 2018 AHA/ACC/multisociety guideline on the management of blood cholesterol
- 2019 ESC/EAS guidelines for the management of dyslipidaemias
- Sniderman et al., apolipoprotein B particles and cardiovascular disease, JAMA Cardiology, 2019
- Biomarker hub: Cardiovascular biomarkers